ALVAC-p53 (Sanofi)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameALVAC-p53 (Sanofi)

Drug Alias NamevCP-207

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulatorsTumor protein p53 modulators

TargetsTumor protein p53

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Active CompaniesSanofi Pasteur

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A